ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc (CYCN)

2.50
0.13
( 5.49% )
Updated: 08:59:15

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
2.50
Bid
2.33
Ask
2.59
Volume
21,338
2.30 Day's Range 2.63
1.27 52 Week Range 9.4699
Market Cap
Previous Close
2.37
Open
2.30
Last Trade
1
@
2.475
Last Trade Time
08:56:46
Financial Volume
US$ 54,722
VWAP
2.5645
Average Volume (3m)
3,572,986
Shares Outstanding
2,710,096
Dividend Yield
-
PE Ratio
-1.22
Earnings Per Share (EPS)
-1.94
Revenue
-
Net Profit
-5.26M

About Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of nex... Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Boston, Massachusetts, USA
Founded
-
Cyclerion Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker CYCN. The last closing price for Cyclerion Therapeutics was US$2.37. Over the last year, Cyclerion Therapeutics shares have traded in a share price range of US$ 1.27 to US$ 9.4699.

Cyclerion Therapeutics currently has 2,710,096 shares outstanding. The market capitalization of Cyclerion Therapeutics is US$6.42 million. Cyclerion Therapeutics has a price to earnings ratio (PE ratio) of -1.22.

CYCN Latest News

Cyclerionā€™s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced an update on its progress in catalyzing the Companyā€™s next stage of growth. The...

Regina Graul, Ph.D., Promoted to Chief Executive Officer

CAMBRIDGE, Mass., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced that Regina Graul, Ph.D., has been promoted to Chief Executive Officer...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.35-12.28070175442.852.94322.3344682.59760485CS
4-0.65-20.63492063493.153.48592.3582133.0057936CS
12-0.06-2.343752.569.46991.2735729865.29080642CS
26-0.99-28.36676217773.499.46991.2715667435.27967269CS
52-0.42-14.38356164382.929.46991.277916555.27377817CS
156-19.7-88.738738738722.229.81.273571967.23880791CS
260-67.1-96.40804597769.6179.21.2743651341.39627432CS

CYCN - Frequently Asked Questions (FAQ)

What is the current Cyclerion Therapeutics share price?
The current share price of Cyclerion Therapeutics is US$ 2.50
How many Cyclerion Therapeutics shares are in issue?
Cyclerion Therapeutics has 2,710,096 shares in issue
What is the market cap of Cyclerion Therapeutics?
The market capitalisation of Cyclerion Therapeutics is USD 6.42M
What is the 1 year trading range for Cyclerion Therapeutics share price?
Cyclerion Therapeutics has traded in the range of US$ 1.27 to US$ 9.4699 during the past year
What is the PE ratio of Cyclerion Therapeutics?
The price to earnings ratio of Cyclerion Therapeutics is -1.22
What is the reporting currency for Cyclerion Therapeutics?
Cyclerion Therapeutics reports financial results in USD
What is the latest annual profit for Cyclerion Therapeutics?
The latest annual profit of Cyclerion Therapeutics is USD -5.26M
What is the registered address of Cyclerion Therapeutics?
The registered address for Cyclerion Therapeutics is 155 FEDERAL STREET, SUITE 700, BOSTON, MASSACHUSETTS, 02110
What is the Cyclerion Therapeutics website address?
The website address for Cyclerion Therapeutics is www.cyclerion.com
Which industry sector does Cyclerion Therapeutics operate in?
Cyclerion Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AMODAlpha Modus Holdings Inc
US$ 4.43
(187.66%)
47.63M
TECXTectonic Therapeutic Inc
US$ 52.50
(104.12%)
2.63M
ATHEAlterity Therapeutics Limited
US$ 5.09
(74.91%)
13.84M
SPGCSacks Parente Golf Inc
US$ 0.9405
(59.41%)
42.03M
KZIAKazia Therapeutics Ltd
US$ 2.19
(58.70%)
68.21M
CLEUChina Liberal Education Holdings Ltd
US$ 0.69
(-91.10%)
26.79M
CRGXCARGO Therapeutics Inc
US$ 3.0958
(-76.53%)
8.19M
FATFAT Brands Inc
US$ 3.4812
(-40.70%)
50.4k
SLXNSilexion Therapeutics Corporation
US$ 1.97
(-37.26%)
5.44M
ZKINZK International Group Co Ltd
US$ 0.3181
(-34.48%)
866k
MGOLMGO Global Inc
US$ 0.1295
(27.34%)
90.21M
KZIAKazia Therapeutics Ltd
US$ 2.20
(59.42%)
68.21M
NAOVNanoVibronix Inc
US$ 0.49051
(27.90%)
50.88M
NVDANVIDIA Corporation
US$ 122.89
(-0.65%)
47.92M
AMODAlpha Modus Holdings Inc
US$ 4.48
(190.91%)
47.66M

CYCN Discussion

View Posts
georgie18 georgie18 3 weeks ago
CYCN...$3.24...🥳... https://schrts.co/BZqjIquT ...Float in 2 Million range...CAMBRIDGE, Mass., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN), today announced an update on its progress in catalyzing the Companyā€™s next stage of growth. The Company is leveraging its legacy soluble guanylate cyclase (sGC) stimulator assets to generate near-term revenues which will be used to implement its strategic building plan without near-term dilution.

ā€œThese agreements demonstrate Cyclerionā€™s progress in maximizing its legacy asset value while redirecting resources toward acquiring potential new assets,ā€ said Regina Graul, Ph.D., President and Chief Executive Officer of Cyclerion. ā€œThese newly finalized agreements, combined with our significant reduction of operating expenses, enable the focused use of our capital to support our anticipated pipeline build in the central nervous system (CNS) space. Concurrently, we plan to raise capital, as needed, to fund our product plans to create value for shareholders and patients.ā€ Graul continued, ā€œCyclerionā€™s diligence team, comprised of committed external experts in their respective fields, is currently in advanced stages of conducting promising asset evaluations, which we believe have the potential to be the new foundation for Cyclerion.ā€

Cyclerion and Akebia have re-negotiated a mutually beneficial amendment to their exclusive license agreement for praliciguat, a systemic sGC stimulator. Under the new license amendment with Akebia, Cyclerion will receive $1.75 million in upfront and near-term payments. In addition, Akebia will assume responsibility for all intellectual property expenses associated with praliciguat after Q1 2025. In 2021, Akebia paid a $3.0 million upfront payment to the Company upon signing of the license agreement, and the Company is eligible to receive additional milestone cash payments of up to approximately $560 million in total potential future development, regulatory, and commercialization milestone payments for praliciguat. In exchange for a reduction in certain development milestone payments, Cyclerion is eligible to receive certain higher, tiered, sales-based royalties ranging from mid-single-digits to twenty percent.

Cyclerion has also entered into an exclusive license option agreement for its vascular sGC stimulator, olinciguat, with a separate entity, wholly controlled by CVCO Therapeutics, Inc., a clinical stage company focused on microvascular dysfunction in cardiovascular, inflammatory and metabolic disease states. Under the terms of the agreement, the potential partner has exclusive rights to evaluate olinciguat during the option period. During the option period, the grantee has assumed responsibility for all ongoing intellectual property-related expenses associated with olinciguat.

As part of its strategic initiatives, Cyclerion previously announced a definitive agreement for the sale of its CNS assets zagociguat and CY3018 to Tisento Therapeutics in May 2023 for an $8 million cash payment and a 10% equity stake in Tisento. The amended agreement for praliciguat, and if the option for olinciguat is exercised, would represent the likely final steps in the monetization of Cyclerionā€™s historical portfolio. Cyclerion believes it is well positioned for the next phase in its overall strategy, to bring in new CNS assets to rebuild the pipeline.
šŸ‘ļø0
LowFloatLopes LowFloatLopes 2 months ago
That's usually exactly what I do sometimes I'll gamble though and stay in longer like I did today :) good strategy 👍🏼
👍️ 1
Strukture Strukture 2 months ago
I just sell the top of the rips buy the dips so long as the trend stays bullish if it goes para after i sell thats ok too
šŸ‘ļø0
LowFloatLopes LowFloatLopes 2 months ago
Right on cue lol 
šŸ‘ļø0
LowFloatLopes LowFloatLopes 2 months ago
IM still holding from that past.. I'm feeling a pop 29 or 10 in the next hour
šŸ‘ļø0
trader59 trader59 2 months ago
Automated wash trading, brazen manipulation of the PPS. The O/S is 2.7M shares, which means that each and every share issued and outstanding has changed hands, on average, over 40 times today. Once they turn their computers off, folks will be trapped with grossly overpriced bags.
šŸ‘ļø0
Strukture Strukture 2 months ago
I was out at 8.20 on that push for a quick 30%
šŸ‘ļø0
tw0122 tw0122 2 months ago
Gave you green light alert at $4s premarket ..lol on the monthly chart all green with 3 hits the 3rd being today 
šŸ‘ļø0
PonkenPlonken PonkenPlonken 2 months ago
mhmm
šŸ‘ļø0
LowFloatLopes LowFloatLopes 2 months ago
Got a sale set at 9.70
šŸ‘ļø0
LowFloatLopes LowFloatLopes 2 months ago
6.45 here :)
šŸ‘ļø0
Strukture Strukture 2 months ago
Re loaded at 6.30 halted up back at HOD 8.40
šŸ‘ļø0
ecmoney ecmoney 2 months ago
Halted again $8.39

Ec
šŸ‘ļø0
LowFloatLopes LowFloatLopes 2 months ago
In at $4.30 out at $7.90 in 15 mins lol 
šŸ‘ļø0
Strukture Strukture 2 months ago
CYCN Boom
šŸ‘ļø0
ecmoney ecmoney 2 months ago
Halted at $6

Rc
šŸ‘ļø0
Invest-in-America Invest-in-America 2 months ago
CYCN: Could NOT find any PR's nor otherwise NEWS anywhere to support this??? (Just the MM machines & algos???)
šŸ‘ļø0
ecmoney ecmoney 2 months ago
Thinking about jumping back in around $5


Ec
šŸ‘ļø0
glenn1919 glenn1919 2 months ago
CYCN.....................................$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$
šŸ‘ļø0
ecmoney ecmoney 2 months ago
Iā€™m out

Easy 300%

Ec
šŸ‘ļø0
tw0122 tw0122 2 months ago
$6.43 + 300% going to cash out now 
šŸ‘ļø0
tw0122 tw0122 2 months ago
$5.49'+ 250%
šŸ‘ļø0
tw0122 tw0122 2 months ago
Party over here also $5.05 + 210%
šŸ‘ļø0
tw0122 tw0122 2 months ago
CYCN $4.88 + 200% 
šŸ‘ļø0
tw0122 tw0122 2 months ago
CYCN 2.62 +92% flip out time 
šŸ‘ļø0
glenn1919 glenn1919 2 months ago
cycn.......................................................https://stockcharts.com/h-sc/ui?s=cycn&p=D&yr=0&mn=2&dy=12&id=p84071410134


...............................nice bounce & volume..................................................
šŸ‘ļø0
tw0122 tw0122 2 months ago
2.49 +'83%
šŸ‘ļø0
tw0122 tw0122 2 months ago
CYCN $2.26 + 70%
šŸ‘ļø0
glenn1919 glenn1919 2 months ago
CYCN.................................https://stockcharts.com/h-sc/ui?s=CYCN&p=W&b=5&g=0&id=p86431144783
šŸ‘ļø0
glenn1919 glenn1919 2 months ago
CYCN.................https://stockcharts.com/h-sc/ui?s=CYCN&p=W&b=5&g=0&id=p86431144783
šŸ‘ļø0
tw0122 tw0122 2 months ago
$2.40- $2.65 first line of resistance breaks solid $3.16 next 
šŸ‘ļø0
tw0122 tw0122 2 months ago
Mini pump
šŸ‘ļø0
Banjo50 Banjo50 6 months ago
It should be five cents. I bid five cents.
šŸ‘ļø0
Invest-in-America Invest-in-America 7 months ago
CYCN: Closed up by 55% today (Etrade), but no posts here for months.
šŸ‘ļø0
dinogreeves dinogreeves 2 years ago
CYCN with big volume could run to the teens.
šŸ‘ļø0
dinogreeves dinogreeves 2 years ago
Boombaska.
šŸ‘ļø0
dinogreeves dinogreeves 2 years ago
One heck of a run coming here fairly soon. Buy the dip and enjoy the rip. CEO paid $8.50 for shares here.
šŸ‘ļø0
Invest-in-America Invest-in-America 2 years ago
CYCN: Hey, & "Little Debbie" is still alive and well!! (See her below!! However, NOT quite as 'cute' as she used to be, though.)



šŸ‘ļø0
subslover subslover 2 years ago
LMAO. You're still partying from Friday night. I know a few peps that need your stuff! :)
šŸ‘ļø0
Invest-in-America Invest-in-America 2 years ago
CYCN: Get ready to PARTY!!! My glorious CYCN HomeBoys, HomeGirls, & straight-up GangBangers!!! I gots the party MUSIC for ya-all, below!!! Who's gonna bring the REFRESHMENTS!!!??? (Hey, Admiral S-L, how about some disruptive, brand-new, very tasty, "Little-Debbie-Cannabis-Infused-Strawberry-Snack-Cakes", Dude!!!???)

šŸ‘ļø0
subslover subslover 2 years ago
Cyclerion's zagociguat gets FDA orphan drug status
šŸ‘ļø0
subslover subslover 2 years ago
Cyclerion's zagociguat gets FDA orphan drug status
šŸ‘ļø0
NYCJR NYCJR 2 years ago
funny its a lot more than that now , close to 12x your call, lol
šŸ‘ļø0
willlbone willlbone 2 years ago
45% layoffs. Bid 25 cents.
šŸ‘ļø0
Banjo50 Banjo50 2 years ago
I think it should be 5 cents. I bid 5 cents EACH for 100 shares. Five cents is fair.
šŸ‘ļø0
kzivann kzivann 2 years ago
Bid for some.

CYCN
šŸ‘ļø0
willlbone willlbone 3 years ago
Bounce back and close the gap.
šŸ‘ļø0
Banjo50 Banjo50 3 years ago
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
šŸ‘ļø0
Banjo50 Banjo50 3 years ago
IS THIS STOCK A SCAM OR WHAT??? I WANT THE TRUTH!!!
šŸ‘ļø0
ClayTrader ClayTrader 4 years ago
* * $CYCN Video Chart 06-08-2021 * *

Link to Video - click here to watch the technical chart video

šŸ‘ļø0

Your Recent History

Delayed Upgrade Clock